Thanks for the info @ Jananch and @ Huwscor - it is much appreciated!!
This is pretty big news for anyone worried about GMV having enough funding to get them through to the new stock exchange listings.
Every time I read about the "footprint / offices / qualified staff etc" that GMV already has around the world, it tells me that there is a big opportunity here - and the latest update on the UK business supports that.
Now we just need to (hopefully in this order!!) - get a few more approvals (especially CFDA for the Prizma), simultaneously get a few more deals over the line, then get the China facility cranking our product - and then successfully list on the new stock exchanges.
Only then can the massive recurring income revenues (that we are all looking forward to) start to hit our accounts / cash flows.
With regards to the SP, hopefully tomorrow marks the beginning of the reversal.
- Forums
- ASX - By Stock
- GMV
- News: GMV G Medical Innovations Holdings Files For U.S. Listing Of Up To $17.3 Million
News: GMV G Medical Innovations Holdings Files For U.S. Listing Of Up To $17.3 Million, page-156
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GMV (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online